At the beginning of January the Oxford Health BRC welcomed 16 delegates from across England to OxCEMM 2020 – our flagship course in experimental medicine for mental health.

Now in its second year the course is has been created to provide a practical grounding in experimental medicine for mental health. The training is designed for clinical and pre-clinical staff and trainees, and medical doctors at any career stage. This year’s diverse cohort included participants from a wide range of backgrounds including psychiatry, pharmacy and cognitive behavioural therapy.

Oxford Health BRC is supporting its second Academic Paper Writing Retreat for Nurses. The retreat will take place at the Department of Psychiatry on 7th, 9th and 10th March 2020….

Calcium ions play a critical role in how brain cells work, and it has long been suspected that an abnormality in calcium might contribute to bipolar disorder. However, findings have been variable and no conclusions could be drawn.

Analysis published in The Lancet has shown that there is significant difference in the way antipsychotic drugs affect body weight and levels of sugar, cholesterol and other fats in the blood.

Register to attend our workshop on 10 December 2019! Patient and Public Involvement (PPI) is an important element of most research funding applications, but how can you get it right…

Memory, coping strategies and resilience immediately following a loss have been shown to predict the path of a bereaved person’s grief according to new research. The study, published in the…

Results of a network meta-analysis published in The Lancet this month will aid clinicians in balancing the risks and benefits of the antipsychotic drugs they are prescribing to treat schizophrenia….

Join our focus group to help develop a new research project! About the research The anonymous use of health records for mental health research has the potential to lead to…

This new course ran for the first time in January 2019, with an engaging and thought-provoking programme of talks, tours of facilities and group discussions. Feedback from participants was uniformly…

Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are…

Oxford Health BRC is supporting a three day Academic Paper Writing Retreat for Nurses planned for this September. The retreat, also sponsored by the Oxford cognitive health Clinical Research Facility…

A new clinical trial beginning on 1st July is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical…

Cristal Health, a new spinout from Oxford, has been developed as a sustainable way to accelerate the UK-CRIS programme. The UK-CRIS network operates a managed service for secure access to…

We are setting up a Patient Advisory Group for a new research trial that will evaluate the drug pramipexole as add-on treatment for people with treatment resistant depression. The Patient…

Are you interested in mental health and dementia research? Join our open day to find out about our current work! When: Monday 20 May 2019, 10am – 2pm Where: St…